ACHFF - Arch Biopartners Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in CAD. All numbers in thousands
Breakdown
ttm
2022-09-30
2021-09-30
2020-09-30
2019-09-30
Total Revenue
0
0
0
67.886
93.876
Operating Expenses
Research Development
1,272
1,272
3,778
1,959
1,575
Selling General and Administrative
772.616
772.616
1,000
2,567
770.673
Total Operating Expenses
1,080
1,080
891.538
4,526
2,346
Operating Income or Loss
-1,080
-1,080
-891.538
-4,458
-2,252
Interest Expense
309.333
309.333
273.307
175.962
110.287
Total Other Income/Expenses Net
-
-
-4.863
5.426
4.419
Income Before Tax
-1,389
-1,389
-1,170
-4,629
-2,358
Income from Continuing Operations
-1,389
-1,389
-1,170
-4,629
-2,358
Net Income
-1,389
-1,389
-1,170
-4,629
-2,358
Net Income available to common shareholders
-1,389
-1,389
-1,170
-4,629
-2,358
Basic EPS
-
-0.02
-0.02
-0.08
-0.04
Diluted EPS
-
-0.02
-0.02
-0.08
-0.04
Basic Average Shares
-
62,159
61,323
59,922
58,646
Diluted Average Shares
-
62,159
61,323
59,922
58,646
EBITDA
-
-1,080
-896.401
-4,453
-2,247